Diagnostic performance with and without artificial intelligence assistance in real-world screening mammography

被引:3
|
作者
Lee, Si Eun [1 ]
Hong, Hanpyo [1 ]
Kim, Eun-Kyung [1 ,2 ]
机构
[1] Yonsei Univ, Yongin Severance Hosp, Dept Radiol, Coll Med, Yongin, South Korea
[2] Yonsei Univ, Yongin Severance Hosp, Dept Radiol, Coll Med, 363 Dongbaekjukjeon Daero, Yongin, Gyeonggi Do, South Korea
关键词
Breast cancer; Digital mammography; Diagnosis; Computer; -assisted; Artificial intelligence; COMPUTER-AIDED DETECTION;
D O I
10.1016/j.ejro.2023.100545
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate artificial intelligence-based computer-aided diagnosis (AI-CAD) for screening mammography, we analyzed the diagnostic performance of radiologists by providing and withholding AI-CAD results alternatively every month. Methods: This retrospective study was approved by the institutional review board with a waiver for informed consent. Between August 2020 and May 2022, 1819 consecutive women (mean age 50.8 +/- 9.4 years) with 2061 screening mammography and ultrasound performed on the same day in a single institution were included. Radiologists interpreted screening mammography in clinical practice with AI-CAD results being provided or withheld alternatively by month. The AI-CAD results were retrospectively obtained for analysis even when withheld from radiologists. The diagnostic performances of radiologists and stand-alone AI-CAD were compared and the performances of radiologists with and without AI-CAD assistance were also compared by cancer detection rate, recall rate, sensitivity, specificity, accuracy and area under the receiver-operating-characteristics curve (AUC). Results: Twenty-nine breast cancer patients and 1790 women without cancers were included. Diagnostic performances of the radiologists did not significantly differ with and without AI-CAD assistance. Radiologists with AI-CAD assistance showed the same sensitivity (76.5%) and similar specificity (92.3% vs 93.8%), AUC (0.844 vs 0.851), and recall rates (8.8% vs. 7.4%) compared to standalone AI-CAD. Radiologists without AI-CAD assistance showed lower specificity (91.9% vs 94.6%) and accuracy (91.5% vs 94.1%) and higher recall rates (8.6% vs 5.9%, all p < 0.05) compared to stand-alone AI-CAD. Conclusion: Radiologists showed no significant difference in diagnostic performance when both screening mammography and ultrasound were performed with or without AI-CAD assistance for mammography. However, without AI-CAD assistance, radiologists showed lower specificity and accuracy and higher recall rates compared to stand-alone AI-CAD.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] VISION-BASED ROBOTICS - A CHALLENGE TO REAL-WORLD ARTIFICIAL-INTELLIGENCE
    INOUE, H
    ADVANCED ROBOTICS, 1995, 9 (04) : 351 - 366
  • [42] The proof of the pudding: in praise of a culture of real-world validation for medical artificial intelligence
    Cabitza, Federico
    Zeitoun, Jean-David
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (08)
  • [43] Artificial intelligence-assisted polyp detection and classification - real-world perspectives
    Cooney, Joseph
    Appiahene, Priscilla
    Ranasinghe, Ian
    Hayat, Jamal
    GUT, 2023, 72 (SUPPL_2) : A214 - A214
  • [44] Validating the Generalizability of Ophthalmic Artificial Intelligence Models on Real-World Clinical Data
    Rashidisabet, Homa
    Sethi, Abhishek
    Jindarak, Ponpawee
    Edmonds, James
    Chan, R. V. Paul
    Leiderman, Yannek I.
    Vajaranant, Thasarat Sutabutr
    Yi, Darvin
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2023, 12 (11):
  • [45] Digital Therapeutics: Virtual Coaching Powered by Artificial Intelligence on Real-World Data
    op den Akker, Harm
    Cabrita, Miriam
    Pnevmatikakis, Aristodemos
    FRONTIERS IN COMPUTER SCIENCE, 2021, 3
  • [46] Patients Perceptions of Artificial Intelligence in a Deep Learning-Assisted Diabetic Retinopathy Screening Event: A Real-World Assessment
    Malerbi, Fernando Korn
    Ventura, Beatriz Mezzomo
    Fischer, Mariana
    Penha, Fernando Marcondes
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2024, 18 (03): : 750 - 751
  • [47] Real-world? artificial intelligence-based opportunistic screening for diabetic retinopathy in endocrinology and indigenous healthcare settings in Australia
    Scheetz, Jane
    Koca, Dilara
    McGuinness, Myra
    Holloway, Edith
    Tan, Zachary
    Zhu, Zhuoting
    O'Day, Rod
    Sandhu, Sukhpal
    MacIsaac, Richard J.
    Gilfillan, Chris
    Turner, Angus
    Keel, Stuart
    He, Mingguang
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [48] EXPLORING THE REAL-WORLD PERFORMANCE OF AN ARTIFICIAL INTELLIGENCE-BASED DIAGNOSTIC DEVICE FOR ASD: AN AGGREGATE ANALYSIS OF EARLY CANVAS DX PRESCRIPTION AND OUTPUT DATA
    Taraman, Sharief
    Shannon, Jennifer
    Liu-Mayo, Stuart
    Kraft, Colleen A.
    Chettiath, Tobin
    Salomon, Mel
    Seal, Minda
    Wall, Dennis
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S294 - S294
  • [49] Exploring the real-world performance of an artificial intelligence-based diagnostic device for autism: an aggregate analysis of early Canvas Dx prescription and output data
    Shannon, J.
    Taraman, S.
    Liu-Mayo, S.
    Salomon, M.
    Seal, M.
    Kraft, C.
    Wall, D.
    ANNALS OF NEUROLOGY, 2023, 94 : S135 - S135
  • [50] Evaluation of a novel artificial intelligence-based screening system for diabetic retinopathy in community of China: a real-world study
    Shuai Ming
    Kunpeng Xie
    Xiang Lei
    Yingrui Yang
    Zhaoxia Zhao
    Shuyin Li
    Xuemin Jin
    Bo Lei
    International Ophthalmology, 2021, 41 : 1291 - 1299